Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.73 |
| ▸ | CA2 | P00918 | 5/20 | 0.73 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.73 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | ORAI1 | Q96D31 | 4/20 | 0.52 |
| ▸ | ORAI2 | Q96SN7 | 4/20 | 0.52 |
| ▸ | ORAI3 | Q9BRQ5 | 4/20 | 0.52 |
| ▸ | TRPV6 | Q9H1D0 | 4/20 | 0.52 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16653533 | 0.85 | CA1 (0.67) | CA1CA2ENPP2CA7CA9 | |
| SCHEMBL4673 | 0.84 | CA2 (1.00) | CA1CA2ENPP2CA7CA9 | |
| SCHEMBL28331836 | 0.82 | CA2 (0.95) | CA1CA2ENPP2CA7CA9 | |
| SCHEMBL26048241 | 0.82 | CA1 (0.70) | CA1CA2ENPP2CA7CA9 | |
| SCHEMBL3737373 | 0.80 | CA1 (0.67) | CA1CA2ENPP2CA7CA9 | |
| SCHEMBL13686655 | 0.80 | CA1 (0.67) | CA1CA2ENPP2CA7CA9 | |
| SCHEMBL12270719 | 0.78 | ORAI1 (0.52) | CA1CA2ENPP2ORAI1ORAI2 | |
| SCHEMBL28832985 | 0.78 | CA2 (0.86) | CA1CA2ENPP2CA7CA9 | |
| SCHEMBL257917 | 0.78 | CA2 (0.86) | CA1CA2ENPP2CA7CA9 | |
| SCHEMBL5836185 | 0.78 | CA2 (0.86) | CA1CA2ENPP2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6600066-B1 | Process for preparing perhalogenated monoorganoboranes or diorganoboranes which makes it possible to obtain these compounds under conditions which can readily be implemented in the industry is described. | BASELL POLYOLEFINE GMBH (DE) | 2003-07-29 | — | — | US | claimed |
| EP-1140947-B1 | METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES | BASELL POLYOLEFINE GMBH (DE) | 2003-03-12 | — | — | EP | claimed |
| US-20260050210-A1 | RESIST COMPOSITION AND METHOD FOR PRODUCING SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-2886548-A1 | METHOD FOR PRODUCING BORINIC ACID DERIVATIVE, AND NOVEL BORINIC ACID DERIVATIVE | Manac Inc. (JP) | 2015-06-24 | — | — | EP | disclosed |
| US-20150105562-A1 | METHOD FOR PREPARING BORINIC ACID DERIVATIVES AND NOVEL BORINIC ACID DERIVATIVES | MANAC INC. (JP) | 2015-04-16 | — | — | US | disclosed |
| EP-1732896-A1 | SUBSTITUTED PYRIDONES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) | Aventis Pharmaceuticals Inc. (US) | 2006-12-20 | — | — | EP | disclosed |
| EP-1339725-B1 | DNA METHYL TRANSFERASE INHIBITORS | PENN STATE RES FOUND (US) | 2006-11-22 | — | — | EP | disclosed |
| WO-2005097750-A1 | SUBSTITUTED PYRIDONES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) | AVENTIS PHARMACEUTICALS INC. (US) | 2005-10-20 | — | — | WO | disclosed |
| US-20050227933-A1 | Treatment of bacterial induced diseases using DNA methyl transferase inhibitors | BENKOVIC STEPHEN J | 2005-10-13 | — | — | US | disclosed |
| EP-1339725-A2 | DNA METHYL TRANSFERASE INHIBITORS | THE PENN STATE RESEARCH FOUNDATION (US) | 2003-09-03 | — | — | EP | disclosed |
| US-6600066-B1 | Process for preparing perhalogenated monoorganoboranes or diorganoboranes which makes it possible to obtain these compounds under conditions which can readily be implemented in the industry is described. | BASELL POLYOLEFINE GMBH (DE) | 2003-07-29 | — | — | US | disclosed |
| EP-1140947-B1 | METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES | BASELL POLYOLEFINE GMBH (DE) | 2003-03-12 | — | — | EP | disclosed |
| EP-1003753-B1 | COMPOUNDS CONTAINING BORON AND ALUMINIUM | BASELL POLYOLEFINE GMBH (DE) | 2003-03-05 | — | — | EP | disclosed |
| US-6417302-B1 | REACTION PRODUCT OF DI(PENTAFLUOROPHENYL) BORINIC ACID AND ORGANOALUMINUM COMPOUND; OLEFIN POLYMERIZATION COORDINATION CATALYSTS | BASELL POLYOLEFINE GMBH (DE) | 2002-07-09 | — | — | US | disclosed |
| WO-2002044184-A2 | DNA METHYL TRANSFERASE INHIBITORS | THE PENN STATE RESEARCH FOUNDATION (US) | 2002-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105562-A1 | METHOD FOR PREPARING BORINIC ACID DERIVATIVES AND NOVEL BORINIC ACID DERIVATIVES | ADORA2B, TPSAB1, ACVR2B | CA1 357/4885CA2 259/4885ENPP2 116/4885 |
| US-20260050210-A1 | RESIST COMPOSITION AND METHOD FOR PRODUCING SAME | MAL2, MCM6, MCM3 | CA1 1842/4885CA2 1817/4885ENPP2 4133/4885 |
| US-20050227933-A1 | Treatment of bacterial induced diseases using DNA methyl transferase inhibitors | DNMT1, TPMT, GNMT | CA1 3630/4885CA2 3114/4885ENPP2 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.